News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Reeve Emma
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 173 shares
@ $59.5242, valued at
$10.3k
Sold 2,995 shares
@ $59.5335, valued at
$178.3k
Sold 3,948 shares
@ $59.5313, valued at
$235k
Sold 157 shares
@ $59.5171, valued at
$9.3k
Sold 1,093 shares
@ $59.532, valued at
$65.1k
Sold 1,402 shares
@ $59.5378, valued at
$83.5k
Exercised 173 options to buy
@ $33.63, valued at
$5.8k
Exercised 2,995 options to buy
@ $33.02, valued at
$98.9k
Exercised 3,948 options to buy
@ $33.63, valued at
$132.8k
Exercised 157 options to buy
@ $33.63, valued at
$5.3k
Exercised 1,093 options to buy
@ $33.02, valued at
$36.1k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 4,000 shares
@ $0
Granted 10,000 options to buy
@ $39.42, valued at
$394.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 3,200 shares
@ $0
Granted 12,000 options to buy
@ $38.1, valued at
$457.2k
|
|
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 60,000 options to buy
@ $36.06, valued at
$2.2M
Disposed/sold 37,527 options to buy
@ $11.5, valued at
$431.6k
Disposed/sold 73,428 options to buy
@ $8.76, valued at
$643.2k
Disposed/sold 11,777 options to buy
@ $8.04, valued at
$94.7k
Disposed/sold 17,666 options to buy
@ $7.6, valued at
$134.3k
Disposed/sold 80,971 options to buy
@ $6.61, valued at
$535.2k
Disposed/sold 66,950 options to buy
@ $35.5, valued at
$2.4M
|
|
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 5,720 shares
@ $35.1058, valued at
$200.8k
Exercised 1,178 options to buy
@ $7.6, valued at
$9k
Exercised 4,542 options to buy
@ $6.61, valued at
$30k
|
|
| 12/16/2020 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 1,000 shares
@ $68, valued at
$68k
Sold 972 shares
@ $68, valued at
$66.1k
Exercised 1,000 options to buy
@ $33.02, valued at
$33k
Exercised 972 options to buy
@ $33.02, valued at
$32.1k
Exercised 1,028 options to buy
@ $33.02, valued at
$33.9k
|
|
| 06/10/2020 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 212 shares
@ $36.5907, valued at
$7.8k
Sold 144 shares
@ $37.6658, valued at
$5.4k
Sold 233 shares
@ $38.3539, valued at
$8.9k
Exercised 589 options to buy
@ $7.6, valued at
$4.5k
|
|
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2020 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 760 shares
@ $35.289, valued at
$26.8k
Exercised 760 options to buy
@ $6.61, valued at
$5k
|
|
| 04/16/2020 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 1,225 shares
@ $35.2022, valued at
$43.1k
Exercised 1,225 options to buy
@ $8.76, valued at
$10.7k
|
|
| 04/13/2020 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 111 shares
@ $35.0179, valued at
$3.9k
Sold 589 shares
@ $35.0179, valued at
$20.6k
Exercised 111 options to buy
@ $8.76, valued at
$972.4
Exercised 589 options to buy
@ $7.6, valued at
$4.5k
|
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2020 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 1,650 shares
@ $0
Granted 10,000 options to buy
@ $51.16, valued at
$511.6k
|
|
| 11/08/2019 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 2,574 shares
@ $16.3088, valued at
$42k
Sold 4,158 shares
@ $17.5945, valued at
$73.2k
Sold 24,264 shares
@ $18.4025, valued at
$446.5k
Sold 6,188 shares
@ $19.2047, valued at
$118.8k
Sold 11,976 shares
@ $20.0093, valued at
$239.6k
Sold 15,740 shares
@ $29.7497, valued at
$468.3k
Sold 726 shares
@ $30.84, valued at
$22.4k
Exercised 56,542 options to buy
@ $6.61, valued at
$373.7k
Exercised 9,084 options to buy
@ $7.6, valued at
$69k
|
|
| 11/07/2019 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $15.504, valued at
$15.5k
Exercised 1,000 options to buy
@ $6.61, valued at
$6.6k
|
|
| 03/08/2019 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Granted 85,500 options to buy
@ $8.76, valued at
$749k
|
|
| 01/24/2019 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $33.02, valued at
$462.3k
|
|
| 12/18/2018 |
4
| Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $33.63, valued at
$470.8k
Granted 1,167 options to buy
@ $33.63, valued at
$39.2k
|
|
| 07/20/2018 |
4
| Reeve Emma (CFO) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Granted 46,811 options to buy
@ $11.5, valued at
$538.3k
|
|
| 12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|